There is no cure for HPV (see HPV Cure), which means that the body's own immune system must get rid of the virus (which it does in a lot of cases). It also means that treatment is focused on treating the signs and symptoms. These treatments will not affect whether your body is able to get rid of the virus or how long it takes.
The best way to protect yourself is to not have sex or to only have sex with one uninfected partner who also only has sex with you (i.e., a mutually monogamous relationship).
HPV can infect male and female genital areas that are covered by a condom, as well as areas not covered by the condom. Using condoms may reduce the risk of getting genital warts and cancer, but they may not completely protect you from the actual virus.
HPV can be prevented with a vaccine. There are currently two different HPV vaccines. Gardasil® (Quadrivalent Human Papillomavirus [Types 6, 11, 16, and 18] Recombinant Vaccine) was the first HPV vaccine approved in the United States. It is approved to prevent cervical cancer, vulvar cancer, vaginal cancer, genital warts, and various precancerous genital lesions caused by certain types of human papillomavirus in girls and women ages 9 through 26.
Gardasil is also approved to prevent genital warts in boys and men in the same age group. Recently, Gardasil was also approved to prevent anal cancer and precancerous anal lesions in males and females age 9 to 26 years.
The second HPV vaccine approved for use in the United States was Cervarix® (Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant). Cervarix is approved for preventing cervical cancer and precancerous cervical lesions in girls and women age 9 through 25 years of age.
Reichman, Richard. Human Papillomavirus Infections. In: Harrison's Principles of Internal Medicine. 13th Edition. New York, McGraw-Hill, 1994.
Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. New England Journal of Medicine 2002; 347(21):1645-1651.
Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus: Infection incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218-226.
Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis 1997; 176 :1076-9.
Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med 1997;102:28-37.
Cervarix [package insert]. Research Triangle Park, NC: GlaxoSmithKline;2011 July.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click